The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ativan 4 mg/ml Solution for injection

4 milligram(s)/millilitre Solution for injection

Pfizer Healthcare IrelandPA0822/090/002

Main Information

Trade NameAtivan 4 mg/ml Solution for injection
Active SubstancesLorazepam
Strength4 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/090/002

Group Information

ATC CodeN05BA Benzodiazepine derivatives
N05BA06 lorazepam

Status

Authorised/WithdrawnAuthorised
Licence Issued27/06/1977
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back